Loading...
Loading...
India accounts for a significant share of global Apixaban exports, with 171+ registered manufacturers shipping to buyers across 98+ countries — yet a handful of companies dominate the shipments. MACLEODS PHARMACEUTICALS LTD holds the largest share at 47.9% (export value: $86.3M). Close behind, APOTEX RESEARCH PRIVATE LIMITED (9.8%, $17.6M). INTAS PHARMACEUTICALS LIMITED (5.3%, $9.6M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
Comprehensive supplier network intelligence dashboard
Flow of Apixaban from leading Indian exporters to their key global customers
Top Suppliers → Customer Networks
The Apixaban export market from India is led by MACLEODS PHARMACEUTICALS LTD, which alone commands a 47.9% share, shipping $86.3M worth of product across 85 shipments. The second-largest exporter, APOTEX RESEARCH PRIVATE LIMITED, contributes $17.6M (9.8%) to the overall market. Combined, the top two suppliers alone account for 57.8% of all Apixaban exports, indicating a relatively concentrated supply base.
Across all 171 tracked manufacturers, the total Apixaban export value stands at $179.9M from 4.5K shipments. The market average shipment value is $40.1K. The single largest buyer relationship in terms of trade value is ALGORITHM SAL, receiving $74.6M worth of product.
The combined buyer network spans 23 named purchasing companies, including ALGORITHM SAL, EVENSEN CONTINENTAL CORPORATION AND, ISIO LABORATOIRES, DKSH MALAYSIA SDN BH, APOTEX INC, and 18 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
MACLEODS PHARMACEUTICALS LTD is the first-largest Apixaban exporter from India, with a market share of 47.9% and a total export value of $86.3M across 85 shipments. Their average shipment value of $1.0M is above the market average of $40.1K, suggesting premium or bulk contract pricing.
MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. ALGORITHM SAL is the dominant customer, accounting for 86.5% of this supplier's tracked business. Top customers include:
• ALGORITHM SAL — $74.6M across 74 shipments (86.5% of this supplier's total exports)
• EVENSEN CONTINENTAL CORPORATION AND — $11.2M across 11 shipments (12.9% of this supplier's total exports)
• ISIO LABORATOIRES — $198.4K across 0 shipments (0.2% of this supplier's total exports)
• DKSH MALAYSIA SDN BH — $135.0K across 0 shipments (0.2% of this supplier's total exports)
• EVENSEN CONTINENTAL CORPORATION AND — $131.8K across 0 shipments (0.2% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $1.0M is 2434% above the market average of $40.1K, consistent with large-order contracts or value-added formulations.
Once Apixaban leaves the manufacturing plants of companies like MACLEODS PHARMACEUTICALS LTD and APOTEX RESEARCH PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $179.9M. Lebanon absorbs the largest share at 41.8% ($75.1M), followed by Canada (18.3%) and Brazil (7.8%).
In Lebanon — the top destination — named importers include ALGORITHM SAL. In Canada, key buyers are APOTEX INC,, APOTEX INC, APOTEX INC,-4100 WESTON ROAD.
This geographic spread reflects Apixaban's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
Comprehensive geographic market intelligence dashboard
Trade flow of Apixaban exports from India — top destination countries and the named companies importing it
Top Countries → Global Importers
Lebanon ranks as the first-largest destination for Apixaban imports from India, with a total trade value of $75.1M across 22 shipments — representing a 41.8% share of all Apixaban exports. The average shipment value of $3.4M is above the global average of $40.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Apixaban importers in Lebanon: ALGORITHM SAL is the largest buyer, accounting for 99.8% ($75.0M) of this market's total imports.
• ALGORITHM SAL — $75.0M (99.8% of Lebanon's total)
Key Insight: Lebanon's per-shipment average of $3.4M (8426% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Lebanon is a key market for Apixaban imports from India.
Canada ranks as the second-largest destination for Apixaban imports from India, with a total trade value of $33.0M across — representing a share of all Apixaban exports. The average shipment value of is
Visual overview of India's apixaban supply chain network — top suppliers, destinations, pricing, and trade routes
This video covers India's apixaban pharmaceutical supply chain network — $179.9M in total trade, 98 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.
Latest developments and market context
Detailed market intelligence for Apixaban — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
APOTEX RESEARCH PRIVATE LIMITED is the second-largest Apixaban exporter from India, with a market share of 9.8% and a total export value of $17.6M across 361 shipments. Their average shipment value of $48.9K is above the market average of $40.1K, suggesting premium or bulk contract pricing.
APOTEX RESEARCH PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• APOTEX INC, — $7.0M across 143 shipments (39.7% of this supplier's total exports)
• APOTEX INC, — $6.2M across 127 shipments (35.2% of this supplier's total exports)
• APOTEX INC,-4100 WESTON ROAD — $3.4M across 70 shipments (19.4% of this supplier's total exports)
• APOTEX INC,-4100 WESTON ROAD — $727.5K across 15 shipments (4.1% of this supplier's total exports)
• APOTEX INC,-4100 WESTON ROAD — $273.8K across 6 shipments (1.6% of this supplier's total exports)
Key Insight: APOTEX RESEARCH PRIVATE LIMITED's per-shipment value of $48.9K is 22% above the market average of $40.1K, consistent with large-order contracts or value-added formulations.
INTAS PHARMACEUTICALS LIMITED is the third-largest Apixaban exporter from India, with a market share of 5.3% and a total export value of $9.6M across 436 shipments. Their average shipment value of $22.0K is below the market average of $40.1K, reflecting a high-volume, competitive pricing strategy.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MYLAN IRELAND LIMITED — $3.9M across 176 shipments (40.5% of this supplier's total exports)
• MYLAN IRELAND LIMITED — $2.5M across 112 shipments (25.6% of this supplier's total exports)
• SANOFI MEDLEY FARMACEUTICA LTDA — $1.1M across 51 shipments (11.7% of this supplier's total exports)
• Accord Healthcare In — $1.1M across 50 shipments (11.4% of this supplier's total exports)
• TO THE ORDER — $1.0M across 47 shipments (10.8% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (436 shipments) at a per-shipment value of $22.0K, indicating a broad distribution network with many smaller, regular orders.
SANDOZ PRIVATE LIMITED is the fourth-largest Apixaban exporter from India, with a market share of 3.8% and a total export value of $6.8M across 500 shipments. Their average shipment value of $13.5K is below the market average of $40.1K, reflecting a high-volume, competitive pricing strategy.
SANDOZ PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• EXPRESS TRAILERS LTD. — $2.8M across 210 shipments (42.1% of this supplier's total exports)
• EXPRESS TRAILERS LIMITED WAREHOUSE 1 — $1.3M across 98 shipments (19.6% of this supplier's total exports)
• EXPRESS TRAILERS LTD. — $909.5K across 67 shipments (13.4% of this supplier's total exports)
• LEK PHARMACEUTICALS D.D., VAT MALTA — $900.6K across 67 shipments (13.3% of this supplier's total exports)
• EXPRESS-TRAILERS LIM — $778.7K across 58 shipments (11.5% of this supplier's total exports)
Key Insight: SANDOZ PRIVATE LIMITED operates with high shipment frequency (500 shipments) at a per-shipment value of $13.5K, indicating a broad distribution network with many smaller, regular orders.
ZYDUS LIFESCIENCES LIMITED is the fifth-largest Apixaban exporter from India, with a market share of 2.0% and a total export value of $3.5M across 194 shipments. Their average shipment value of $18.1K is below the market average of $40.1K, reflecting a high-volume, competitive pricing strategy.
ZYDUS LIFESCIENCES LIMITED serves 5 named buyers in our database. BRAINFARMA INDUSTRIA QUIMICA E is the dominant customer, accounting for 62.5% of this supplier's tracked business. Top customers include:
• BRAINFARMA INDUSTRIA QUIMICA E — $2.2M across 121 shipments (62.5% of this supplier's total exports)
• ZYDUS NIKKHO FARMACE — $595.5K across 33 shipments (16.9% of this supplier's total exports)
• COSMED IND. DE COSM. — $374.1K across 21 shipments (10.6% of this supplier's total exports)
• SUNSHINE HEALTHCARE — $179.8K across 10 shipments (5.1% of this supplier's total exports)
• HAPHARCO J.S.C. BRAN — $171.7K across 9 shipments (4.9% of this supplier's total exports)
Key Insight: ZYDUS LIFESCIENCES LIMITED operates with high shipment frequency (194 shipments) at a per-shipment value of $18.1K, indicating a broad distribution network with many smaller, regular orders.
NATCO PHARMA LIMITED is the fifth-largest Apixaban exporter from India, with a market share of 0.6% and a total export value of $1.1M across 72 shipments. Their average shipment value of $15.6K is below the market average of $40.1K, reflecting a high-volume, competitive pricing strategy.
NATCO PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• NATCO PHARMA (CANADA — $415.3K across 27 shipments (36.9% of this supplier's total exports)
• ABC INTERNATIONAL LT — $348.2K across 22 shipments (30.9% of this supplier's total exports)
• NATCOFARMA DO BRASIL LTDA — $170.7K across 11 shipments (15.2% of this supplier's total exports)
• ATLANTA MEDICARE CO — $110.8K across 7 shipments (9.8% of this supplier's total exports)
• NATCO LIFESCIENCES P — $81.4K across 5 shipments (7.2% of this supplier's total exports)
Key Insight: NATCO PHARMA LIMITED operates with high shipment frequency (72 shipments) at a per-shipment value of $15.6K, indicating a broad distribution network with many smaller, regular orders.
Named Apixaban importers in Canada: APOTEX INC, is the largest buyer, accounting for 23.2% ($7.6M) of this market's total imports.
• APOTEX INC, — $7.6M (23.2% of Canada's total)
• APOTEX INC — $6.2M (18.9% of Canada's total)
• APOTEX INC,-4100 WESTON ROAD — $3.4M (10.4% of Canada's total)
Key Insight: Canada's per-shipment average of $69.2K (73% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Apixaban imports from India.
Brazil ranks as the third-largest destination for Apixaban imports from India, with a total trade value of $14.1M across 127 shipments — representing a 7.8% share of all Apixaban exports. The average shipment value of $111.1K is above the global average of $40.1K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Apixaban importers in Brazil: BRAINFARMA INDUSTRIA QUIMICA E is the largest buyer, accounting for 40.6% ($5.7M) of this market's total imports.
• BRAINFARMA INDUSTRIA QUIMICA E — $5.7M (40.6% of Brazil's total)
• NATCOFARMA DO BRASIL LTDA — $2.5M (17.6% of Brazil's total)
• SANOFI MEDLEY FARMACEUTICA LTDA — $1.7M (12.3% of Brazil's total)
Key Insight: Brazil's per-shipment average of $111.1K (177% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Apixaban imports from India.
Colombia ranks as the fourth-largest destination for Apixaban imports from India, with a total trade value of $13.4M across 41 shipments — representing a 7.4% share of all Apixaban exports. The average shipment value of $326.4K is above the global average of $40.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Apixaban importers in Colombia: EVENSEN CONTINENTAL CORPORATION AND is the largest buyer, accounting for 94.1% ($12.6M) of this market's total imports.
• EVENSEN CONTINENTAL CORPORATION AND — $12.6M (94.1% of Colombia's total)
Key Insight: Colombia's per-shipment average of $326.4K (715% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Colombia is a key market for Apixaban imports from India.
Malta ranks as the fifth-largest destination for Apixaban imports from India, with a total trade value of $13.2M across 282 shipments — representing a 7.3% share of all Apixaban exports. The average shipment value of $46.9K is above the global average of $40.1K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Apixaban importers in Malta: EXPRESS TRAILERS LTD. is the largest buyer, accounting for 26.2% ($3.5M) of this market's total imports.
• EXPRESS TRAILERS LTD. — $3.5M (26.2% of Malta's total)
• LEK PHARMACEUTICALS D.D., VAT MALTA — $3.2M (24.4% of Malta's total)
• PHARMADOX HEALTHCARE LTD — $1.6M (12.0% of Malta's total)
Key Insight: Malta's per-shipment average of $46.9K (17% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Malta is a key market for Apixaban imports from India.
Top supplier: 5 customers
6 suppliers → 98 countries
Network value: $179.9M
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,492 Verified Shipments
171 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists